Also, on a side note, cheer leading a stock into pie in the sky...

Also, on a side note, cheer leading a stock into pie in the sky land is not helpful to anyone. At current arr of ~ 7 mil, it puts this cash burner on a revenue multiple of 10. That is not cheap! It is currently trading at 33% below its IPO price, even AFTER this so called "transformational" deal (really, a glorified CR until it proven otherwise) had been penned.

It needs to up its revenue by a factor of 3 just to break even. So if you're telling me that this is the next phase of normal care of the general public, the facts don't support it. This is an EMERGING market (Microbas own words if you read the prospectus).

Sure we can all speculate on what the next big thing in healthcare, and Microba might be it!